Ruchi Mittal

Dr Ruchi Mittal

Senior Health Economist

School of Public Health

College of Health


Working as a Health Economist for Adelaide Health Technology Assessment (AHTA).

Research Interests

Health Economics, Decision Analytic Modeling, Data analysis, Health Technology Assessment, Evidence Based Medicine and Clinical Epidemiology.

Publications

Reports for External bodies

  • Laka, M, Luc, I, Morona, J, Hill, H, Mittal, R, Schubert, C, Newton, S (2025). Newborn bloodspot screening for mucopolysaccharidosis, Type II (MPS II). MSAC Application 1776, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Milverton, J, Mittal, R, Hancock, S, Carter, D, Schubert, C, Newton, S (2025). Newborn bloodspot screening for glycogen storage disease, Type II (Pompe disease). MSAC Application 1774, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Mittal, R, Morona, J, Salinger, K, Liufu, V, Ellery, B, Schubert, C, Newton, S (2025). Newborn bloodspot screening for mucopolysaccharidosis, Type I (MPS I; Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome). MSAC Application 1775, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Mittal, R, Giles, L, Tamblyn, D. Selected PBS listed drugs: predicted estimates versus actual data for drugs reviewed by DUSC in 2013–2020 (2024). Review Report. Commonwealth of Australia, Canberra, ACT.
  • Morona J, Mittal R, Hill H, Kessels S, Laka M, Parsons J, Salinger K, Schubert C, Newton S (2023). Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours. MSAC Application 1702, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Morona J, Mittal R, Laka M, Parsons J, Schubert C (2022). Whole Genome Sequencing for the diagnosis of mitochondrial disease. MSAC Application 1675, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Kessels S, Mittal R, Newton S and Tamblyn D. (2022). Review of Different Minimally Invasive Therapeutic Approaches for the Management of Patients with Benign Prostatic Hyperplasia (BPH). MSAC Application 1697, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Mittal R, Milverton J, Schubert C, Parsons J (2021). Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). MSAC Application 1564, Re-submission assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Newton S, Mittal R, Hill H, Milverton, J, Carter D, Schubert C. (2020) Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiac rhythm disorders. MSAC Application 1598, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Milverton J, Mittal R, Bellman S, Parsons J, Schubert C. (2020). Antibody testing for neuromyelitis optica spectrum disorder (NMOSD). MSAC Application 1582, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Kessels S, Mittal R, Morona J, Schubert C, Newton S (2019). Faecal calprotectin testing in patients suspected of inflammatory bowel disease or irritable bowel syndrome presenting to primary care. MSAC Application 1353.1 Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Kessels, S, Newton, S, Vogan, A, Mittal, R, Schubert, C, Carter, D, Ellery, B, Merlin, T (2019). Clinical utility card for heritable mutations associated with familial hypercholesterolaemia. MSAC Application CUC 1534. Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Mittal, R, Kessels, S, Morona, J, Newton, S, Vogan, A and Schubert, C (2018). Clinical utility card for heritable mutations which increase risk in colorectal and endometrial cancer – Lynch syndrome and adenomatous polyposis syndrome – Economic and Financial Evaluation. MSAC Application 1504, Clinical Utility Card Economic and Financial Evaluation. Commonwealth of Australia, Canberra, ACT.
  • Milverton, J., Mittal, R., Carter, D. A., Kessels, S., Newton, S., Schubert, C., Merlin, T. (2018). Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future (MSAC Application 1435 Part B, Assessment Report). Canberra: Commonwealth of Australia.
  • Kessels, S., Mittal, R., Morona, J., Newton, S., Schubert, C., Milverton, J., & Merlin, T. (2018). Anti-Müllerian hormone testing for female patients preceding or following gonadotoxic treatment (MSAC 1434).
  • Morona J, Mittal R, Newton S, Salinger K, Carter D, Schubert C, & Merlin TL (2017). Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility. MSAC 1435 Part A, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Morona JK, Mittal R. (2017) Substitution of 68Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369. Mini-assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Mittal R, Kessels S, Newton S, Milverton J, Parsons J, Morona J, Schubert C, Merlin T (2016). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene - Resubmission. MSAC application 1216.1. Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Milverton, J., Mittal, R., Parsons J., Schubert C., and Newton, S. (2016). Microwave tissue ablation for primary and secondary liver tumours. MSAC Application 1402, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Kessels S, Mittal R, Morona J, Newton S, Ellery B, Milverton J, Parsons J, Vogan A, Schubert C and Merlin T (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies. MSAC Application no. 1393, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Morona JK, Kessels S, Vogan A, Mittal R, Newton S, Parsons J, Milverton J, Ellery B and Merlin T. (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease. MSAC Application Number 1237, Assessment Report. Commonwealth of Australia, Canberra, ACT.
  • Kessels SJM, Morona JK, Mittal R, Vogan A, Newton S, Schubert C, Merlin T (2015). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. MSAC application 1216, Assessment Report. Commonwealth of Australia, Canberra, ACT.

 Journals

  • Hill, H, Mittal, R & Merlin T. Evidence - based funding of new imaging applications and technologies by Medicare in Australia: How it happens and how it can be improved. J. Med. Imag. Rad. Onc., 2022. https://doi.org/10.1111/1754-9485.13386
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Comparison Datasets for Benchmarking QSAR Methodologies in Lead Optimization. J Chem Info Model 2009, Article ASAP.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. The Effect of Molecular Fields, Lattice Spacing and Analysis Options on CoMFA Predictive Ability. Quant Struct-Act Rel Comb Sci 2009, 28, 637-644.
  • Mittal, R.R., Harris L., McKinnon, R.A. & Sorich, M.J. Partial Charge Calculation Method Affects CoMFA QSAR Prediction Accuracy. J Chem Info Model 2009, 49, 704-709.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Effect of steric molecular field settings on CoMFA predictivity. J Mol Model 2008, 14, 59-67.
  • Dias, M.M., Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Systematic statistical comparison of comparative molecular similarity indices analysis molecular fields for computer-aided lead optimization. J. Chem. Inf. Model. 2006, 46, 2015-21.

Conference Proceedings

  • Mittal, R. and C. Schubert, Cost-effectiveness of cryopreserving sperm in males undergoing gonadotoxic therapy, in ISPOR Asia-Pacific. 2018, Value in Health: Tokyo, Japan. p. S15.
  • Mittal, R., Scubert, C. Multiple populations in a single economic evaluation of CFTR testing (Conference Poster). AHTA, The University of Adelaide. HTAi Conference Rome 2017.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. 3D QSARs Scope and Limitations. Sansom Institute, UniSA, Research Colloquium 2008.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. 3D QSARs Based On Molecular Similarities. APSA 2007.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J.  Quantitative structure activity relationship based on molecular similarities. ASCEPT 2007.
  • Harris L., Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Effect of Partial Charge Calculation Method on CoMFA and CoMSIA QSAR. APSA 2007.
  • Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Evaluation of 3D QSAR Techniques for Computer-Aided Lead Optimisation: Comparison And Prediction Of Steric Fields. APSA 2005.
  • Dias, M.M., Mittal, R.R., McKinnon, R.A. & Sorich, M.J. Evaluation of Hydrophobic and H-Bonding Molecular Fields for 3d-QSAR Computer-Aided Lead Optimisation. APSA 2005.

Date Institution name Country Title
University of South Australia Australia PhD
University of Newcastle Australia Australia Graduate Diploma in Clinical Epidemiology
University of South Australia Australia Graduate Certificate in Research Commercialisation
Indira Gandhi National Open University India Masters in Computer Applications
Indira Gandhi National Open University India Bachelors in Computer Applications

Date Title Institution Country
2017 - 2017 Decision Analytic Modelling for Economic evaluations The University of York United Kingdom
TreeAge in Healthcare Modelling TreeAge Australia
Healthcare Modelling systems Modelling workshop Flinders University Australia

Year Citation
2018 Mittal, R., & Schubert, C. M. (2018). COST-EFFECTIVENESS OF CRYOPRESERVING SPERM IN MALES UNDERGOING GONADOTOXIC THERAPY. Poster session presented at the meeting of VALUE IN HEALTH. ELSEVIER SCIENCE INC.
DOI
2017 Mittal, R., & Schubert, C. M. (2017). Multiple populations in a single evaluation of CFTR testing. Poster session presented at the meeting of the 14th Annual Health Technology Assessment international (HTAi) Conference. Rome, Italy.

Year Citation
2022 Kessels, S., Mittal, R., Newton, S., & Tamblyn, D. (2022). Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia (MSAC FFP review 1697). Canberra: Commonwealth of Australia.
2022 Newton, S., Allani, P., Salinger, K., Morona, J., Mittal, R., & Vogan, A. (2022). Whole genome sequencing of mycobacterium to identify antimicrobial-resistant pathogens (MSAC Application 1646). Canberra: Commonwealth of Australia.
2022 Morona, J., Mittal, R., Laka, M., Parsons, J., & Schubert, C. (2022). Whole Genome Sequencing for the diagnosis of mitochondrial disease. (MSAC APplication 1675). Canberra, ACT: Commonwealth of Australia, Canberra, ACT.
2021 Mittal, R., Milverton, J., Schubert, C., & Parsons, J. (2021). Review of immunoglobulin use for Chronic Inflammatory Demyelinating Polyneuropathy (MSAC Application no 1564 re-submission assessment report). Canberra, ACT: Commonwealth of Australia 2021.
2020 Milverton, J., Mittal, R., Bellman, S., Parsons, J., & Schubert, C. (2020). Antibody testing for neuromyelitis optica spectrum disorder (NMOSD). Commonwealth of Australia, Canberra, ACT.
2020 Newton, S., Mittal, R., Hill, H., Milverton, J., Carter, D., & Schubert, C. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiac rhythm disorders (MSAC Application 1598). Canberra: Commonwealth of Australia.
2020 Newton, S., Mittal, R., Hill, H., Milverton, J., Carter, D., & Schubert, C. (2020). Clinical utility card for genetic testing for diagnosis of inheritable cardiac rhythm disorders. Canberra: Commonwealth of Australia.
2019 Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia.
2019 Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Technical report to supplement clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia.
2019 Kessels, S., Mittal, R., Morona, J., Schubert, C., & Newton, S. (2019). Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care. (MSAC Application 1353.1). Canberra, ACT.
2018 Milverton, J., Mittal, R., Carter, D. A., Kessels, S., Newton, S., Schubert, C., . . . Merlin, T. (2018). Processing and cryopreservation of ovarian tissue prior to or after gonadotoxic treatment to preserve fertility in females for the future (MSAC Application 1435 Part B, Assessment Report). Canberra: Commonwealth of Australia.
2018 Kessels, S., Mittal, R., Morona, J., Newton, S., Schubert, C., Milverton, J., & Merlin, T. (2018). Anti-Müllerian hormone testing for female patients preceding or following gonadotoxic treatment (MSAC 1434).
2018 Mittal, R., Kessels, S., Morona, J., Newton, S., Vogan, A., & Schubert, C. (2018). Heritable mutations which increase risk in colorectal and endometrial cancer - Lynch syndrome and adenomatous polyposis syndrome. Economic and financial evaluation. (MSAC clinical utility card 1504). Canberra: Commonwealth of Australia.
2017 Mittal, R., Kessels, S., Newton, S., Milverton, J., Parsons, J., Morona, J., . . . Merlin, T. (2017). Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene - Resubmission (MSAC application 1216.1). Canberra: Commenwealth of Australia.
2017 Morona, J., & Mittal, R. (2017). Substitution of 68Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369: Mini-assessment Report (Mini-assessment Report).
2017 Morona, J., Mittal, R., Newton, S., Salinger, K., Carter, D. A., Schubert, C., & Merlin, T. (2017). Processing and cryopreservation of semen, sperm and testicular tissue prior to or after gonadotoxic treatment to preserve future fertility (MSAC 1435 Part A, Assessment Report). Canberra: Commonwealth of Australia.
2016 Morona, J., Kessels, S., Vogan, A., Mittal, R., Newton, S., Parsons, J., . . . Merlin, T. (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease (MSAC application number 1237). Canberra, ACT: Commonwealth of Australia.
2016 Kessels, S., Mittal, R., Morona, J., Newton, S., Ellery, B., Milverton, J., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies (MSAC Application no. 1393). Canberra, ACT: Commonwealth of Australia.
2016 Milverton, J., Mittal, R., Parsons, J., Schubert, C., & Newton, S. (2016). Microwave tissue ablation for primary and secondary liver cancer (MSAC Application no. 1402). Australia: Commonwealth of Australia.
2015 Kessels, S., Morona, J., Mittal, R., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2015). Testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene (1216). http://www.msac.gov.au/internet/msac/publishing.nsf/Content/B1083E11E4A3006BCA257BCB0081849E/$File/1216-MSAC-CA-CFTR.pdf: Commonwealth of Australia.
  • Sansom Institute Postgraduate Award, UniSA
  • Tuition scholarship and stipend for Degree Certificate in Research Commercialization course
  • Sansom Institute Publication Grants

Date Institution Department Organisation Type Country
2018 - 2023 National Health and Medical Research Council National Health and Medical Research Council Health services and related Australia

Connect With Me

External Profiles